Association between mixture of persistent organic pollutants and thyroid pathologies in a Belgian population. by Dufour, Patrice et al.
Contents lists available at ScienceDirect
Environmental Research
journal homepage: www.elsevier.com/locate/envres
Association between mixture of persistent organic pollutants and thyroid
pathologies in a Belgian population
Patrice Dufoura,b,∗, Catherine Pirarda,b, Patrick Petrossiansc, Albert Beckersc, Corinne Charliera,b
a Laboratory of Clinical, Forensic and Environmental Toxicology, University of Liege (ULg), CHU (B35), 4000, Liege, Belgium
b Center for Interdisciplinary Research on Medicines (C.I.R.M.), University of Liege (ULg), CHU (B35), 4000, Liege, Belgium
c Department of Endocrinology, University of Liege (ULg), CHU (BE 035), 4000, Liege, Belgium







A B S T R A C T
Previous years, the incidence of autoimmune thyroid diseases has increased worldwide. The presence of many
pollutants in the environment suspected to be thyroid disruptors may have contributed to the observed increase.
Unfortunately, the results from epidemiological studies assessing the association between pollution and thyroid
disorders remain inconsistent, maybe due to a nearly complete neglect of the mixture effect. The blood levels of
12 brominated flame retardants, 3 polychlorinated biphenyls, 16 organochlorine pesticides, 7 perfluoroalkyl
substances and 16 phenolic organohalogens were measured in 35 hypothyroid and 44 hyperthyroid volunteers
and in 160 individuals from the general population designed as controls. Weighted quantile sum (WQS) re-
gressions were performed to compute indexes representing the mixture of POPs, and we assessed the relations
with thyroid disorders. Nineteen pollutants were detected in more than 40% of the individuals and were thus
included in the WQS indexes. The WQS index was statistically significantly associated with an increased odds of
hypothyroidism (odds ratio (OR) = 98.1; 95% CI: 5.51–1747) with the highest weights attributed to PCB 138
(w = 0.210), 3-OH-CB 180 (w = 0.197), 4-OH-CB 146 (w = 0.188), 4’,4-DDE (w = 0.156) while there were no
evidence of a relation with increased odds of hyperthyroidism. Given the relative low number of individuals
included in the present investigation, standard WQS methodology could not be used, this study should thus be
considered as a preliminary, hypothesis-generating study. Nevertheless, these results highlighted the importance
of considering the potential effect of chemical mixture when studying endocrine disruptors.
1. Introduction
Diseases affecting the thyroid are among the most common endo-
crine pathologies. In area where the iodine intake is sufficient (most of
the European countries are considered as iodine-sufficient area), auto-
immunity is the most common etiology for thyroid disorders (Lind
et al., 1998; Garmendia Madariaga et al., 2014). Hashimoto's disease or
autoimmune hypothyroidism is characterized by an autoimmune de-
struction of the thyroid follicles leading to a decreased production and
secretion of the thyroid hormones (THs). In Graves' disease or auto-
immune hyperthyroidism, the antibodies are directed against the
thyroid stimulating hormone (TSH) receptor. These antibodies stimu-
late the receptor, which leads to a continuous activation of the thyr-
ocytes and a higher level of production and secretion of TH (Benvenga
et al., 2015; McGrogan et al., 2008; McLeod and Cooper, 2012). The
incidence of these pathologies has been rising and this increase is
probably the consequence of environmental factors such as smoking or
nutritional habits (Leese et al., 2008; McLeod and Cooper, 2012; Rizzo
et al., 2010). Several epidemiological studies also highlighted that the
risk to present thyroid diseases or thyroid autoantibodies is higher for
individuals exposed to high levels of environmental pollutants
(Chevrier et al., 2010; Langer et al., 2007; Melzer et al., 2010; Oulhote
et al., 2016; Schell et al., 2009; Turyk et al., 2008). Nevertheless, these
associations are not firmly established since some authors have found
no correlation between pollutant exposure and the thyroid disease in-
cidence (Benson et al., 2018; Chan et al., 2011; Donato et al., 2008;
Yard et al., 2011). However, the discrepancies may be explained by
several factors, among them, the paucity of validated statistical meth-
odology to evaluate the risks of chemical mixture.
Most toxicological researches and in particular the research on en-
docrine disruptors have been focused on single chemical effects
(Kortenkamp, 2007; Kortenkamp and Faust, 2018; Martin et al., 2013).
However, a growing number of investigations showed that the effects of
mixture components can be additive, and that each component
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contributes to the combination effect in relation to its dose and its
potency. An important consequence of this observation is the “some-
thing from nothing” phenomenon: the combination of a sufficient
number of chemicals at individual concentrations associated with zero
effect will jointly produce an observable effect (Kortenkamp, 2014;
Faust et al., 2001; Hermens et al., 1985; Silva et al., 2002; Hass et al.,
2007; Villa et al., 2012). Many chemicals which largely have con-
taminated the environment and the human populations are suspected to
be thyroid disruptors (Boas et al., 2012), among them, the persistent
organic pollutants (POPs) such as polychlorinated biphenyls (PCBs),
brominated flame retardants (BFRs), organochlorine pesticides, per-
fluoroalkyl substances (PFASs) or phenolic organohalogens (POHs).
Moreover, the effects of these thyroid disruptor have been demon-
strated to be additive or even synergic (Chen et al., 2016; Crofton et al.,
2005; Miller et al., 2012) in laboratory studies on rats. A better as-
sessment of the effects associated with mixtures of thyroid disruptors at
the human population scale is thus necessary to clarify the potential
associations between the rise of thyroid pathology cases and the ex-
posure to environmental pollutants.
However, several issues arise when one tries to assess health effects
of xenobiotics mixture: standard multiple regression models which in-
clude multiple pollutants are not suitable for these analyses, because to
include a large number of pollutants into regression leads to models
with instable coefficient estimates and reduced statistical power.
Moreover, many chemicals present in the environment are highly in-
tercorrelated making difficult the identification of the pollutant really
responsible for the effect usually observed with a classical multivariate
regression model (Billionnet et al., 2012). Advanced statistical meth-
odologies are thus required. To the best of our knowledge, only Berg
et al. (2017) applied such methodologies to assess the relations between
a mixture of POPs and the thyroid function at a human population
scale. In order to avoid multicollinearity issues and to reduce the di-
mensionality of the statistical models, they performed partial least re-
gression, principal component analysis and hierarchical clustering.
These methods allowed assessing the associations between concentra-
tions of PCBs and PFASs and the thyroid hormone levels in the blood of
Swedish pregnant women. Nevertheless, these reduction methods were
unable to identify the pollutants effectively associated with the health
outcome. A recent method called weighted quantile sum (WQS) re-
gression developed by Gennings et al. (2010) and improved by Carrico
et al. (2015) demonstrated its capability to overcome collinearity issues
and to provide parsimonious and more accurate statistical models while
allowing the identification of the “bad actors”.
In the present work, we applied the WQS regression to assess the
relations between the concentrations of 12 BFRs, 3 PCBs, 16 organo-
chlorine pesticides, 7 PFASs and 16 POHs measured in the serum and
the risk of presenting autoimmune thyroid pathology in a Belgian po-
pulation.
2. Materials and methods
2.1. Study participants
This case-control study was focused on patients diagnosed for au-
toimmune thyroid pathologies. In collaboration with the department of
Endocrinology of the University Hospital of Liege (Belgium), we re-
cruited 35 individuals suffering from Hashimoto's hypothyroidism and
44 patients suffering from Graves' hyperthyroidism. The recruitment
took place from February 2015 to November 2018. The other inclusion
criteria were (1) to live in Belgium for at least 10 years and (2) to have
been diagnosed less than 2 years ago. In 2015, 252 individuals from the
general population living in the Province of Liege were recruited in
collaboration with the Office of the Province of Liege (Pirard et al.,
2018) and some additional participants (n = 15) were newly recruited
in November 2018. Among these participants, 70 were randomly de-
signed as controls for cases of hypothyroidism and 90 for cases of
hyperthyroidism (so that there are 2 controls for one case), controls had
to be frequency matched to cases by sex and age (within 5 years
groups). All the volunteers signed an informed consent and provided a
blood sample in clot activator tubes without gel. A questionnaire was
also administered. The blood samples were stored at 4 °C before their
transfer to the Toxicology lab (within the day), and were then cen-
trifuged at 3000 rpm for 5 min to collect the serum fractions which
were stored at −20 °C.
2.2. POPs analyses
2.2.1. Organochlorine pesticides and PCBs
Organochlorine pesticides (namely, α-, β-, γ-hexachlorohexane
(HCH), hexachlorobenzene (HCB), aldrine, endrine, dieldrine, oxy-
chlordane, trans-heptachlor epoxide, trans-chlordane, trans- and cis-
nonachlor, 2,4′- and 4,4′-dichlorodiphenyldichloroethylene (DDE),
2,4′-dichlorodiphenyltrichloroethane (DDT) and β-endosulfan) and
PCBs (namely PCB 138, -153, −180) were analyzed according the
method described in Pirard et al. (2018). Briefly, 500 μL of serum
sample denatured with acetonitrile were extracted twice with 5 mL of a
hexane/acetone mixture (90/10, v/v). The organic phase was purified
on a Bond Elut Certify cartridge (Agilent technologies) and then eva-
porated till 500 μL. The residual volume was transferred to a GC vial
containing 50 μL of nonane as keeper and let slowly evaporated at room
temperature. The extracts were then analyzed on an Agilent 7890 A GC
coupled with an Agilent 7000 A triple quad mass spectrometer (MS)
operating in electron capture negative ionization mode. The separation
took place on a 30 m SGE HT8 column (Agilent technologies).
2.2.2. BFRs
The method employed to determinate BFRs (namely, poly-
brominated diphenylethers (PBDE) −47, −99, −100, −153,- 154,
−183 and 209, polybromobiphenyl 153 (PBB 153), hexabromobenzene
(HBBz), pentabromoethylbenzene (PBEB), 2-ethylhexy-2,3,4,5-tetra-
bromobenzoate (EHTBB) and 1,2-bis(2,4,6-tribromophenoxy) ethane
(BTBPE)) in serum was developed and validated by Pirard and Charlier
(2018). Briefly, 1 mL of serum sample was denatured with glacial acetic
acid before being extracted twice with 4 mL of a hexane/acetone
mixture (95/5, v/v). Organic phase were evaporated till 500 μL and
then purified on a PHREE cartridge (Phenomenex). The eluate was
transferred to a GC vial containing 50 μL of nonane as keeper and let
slowly evaporated at room temperature. The chromatographic analysis
was performed on an Agilent 7890 A GC/7000 A triple quad MS op-
erating in electron capture negative ionization mode and equipped with
a 15 m Rtx-1614 column (Restek).
2.2.3. POHs
The analytical procedure used for the determination of POHs
(namely, pentachlorophenol (PCP), tetrabromobisphenol A (TBBPA),
2,4,6-tribromophenol (2,4,6-TBP), 2,3,6-tribromophenol (2,3,6-TBP),
2,4,5-tribromophenol (2,4,5-TBP), 2,3,4,6-tetrabromophenol (2,3,4,6-
TeBP) 6-hydroxy-polybromodiphenylether 47 (6-OH-BDE 47), 5-hy-
droxy-polybromodiphenylether 47 (5-OH-BDE 47), 5′-hydroxy-poly-
bromodiphenylether 99 (5′–OH–BDE 99), 4-hydroxy-polychlorinated
biphenyl 107 (4-OH-CB 107), 3-hydroxy-polychlorinated biphenyl 138
(4-OH-CB 138), 4-hydroxy-polychlorinated biphenyl 146 (4-OH-CB
146), 3-hydroxy-polychlorinated biphenyl 153 (3-OH-CB 153), 4-hy-
droxy-polychlorinated biphenyl 172 (4-OH-CB 172), 3-hydroxy-poly-
chlorinated biphenyl 180 (3-OH-CB 180) and 4-hydroxy-poly-
chlorinated biphenyl 187 (4-OH-CB 187)) has been described in Dufour
et al. (2016). In summary, 1 mL of serum sample was denatured with
3 mL of a water/formic acid/2-propanol mixture (50/40/10, v/v). The
sample was next loaded and purified on an Oasis MAX SPE cartridge
(Waters) and eluted with 5 mL of methanol/formic acid mixture (98/2,
v/v). The volume of the eluate was reduced by evaporation to ap-
proximately 1 mL and then extracted with 5 mL hexane. The organic
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phase was evaporated to dryness and the residue was reconstituted with
dichloromethane and methanol. The extract was then derivatized with
trimethylsilyldiazomethane during 30 min at 40 °C. The derivatized
extract is then evaporated to dryness, reconstituted in 70 μL of iso-
octane and finally transferred to a GC vial. An Agilent 7890 A GC/
7000 A triple quad MS operating in electron capture negative ionization
mode and equipped with a 30 m HP-5MS column (Agilent) was used for
the final analysis.
2.2.4. PFASs
We measured the concentrations of PFASs (namely, perfluorooctane
sulfonate (PFOS), perfluorohexane sulfonate (PFHxS), per-
fluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), per-
fluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUdA) and
perfluoroheptanoic acid (PFHpA)) in serum by employing the method
of Kärrman et al. (2007) slightly modified as detailed in Dufour et al.
(2018). Shortly, 1 mL of serum was denatured with acid formic. Next,
the sample was loaded and purified on an Oasis WAX SPE cartridge
(Waters) and eluted with 2 × 2 mL of ammonium hydroxide 2% in
methanol. The eluate was evaporated to dryness and reconstituted in
80 μL of a 2 mM ammonium acetate in acetonitrile/2 mM ammonium
acetate in water mixture (20/80, v/v). The analytical separation was
performed using an Acquity Ultra Performance UHPLC (Waters)
equipped with a Kinetex F5 Core-Shell column (Phenomenex) and op-
erating in gradient mode with 2 mM ammonium acetate in acetonitrile
and 2 mM ammonium acetate in water mobile phases. A Quattro Pre-
mier XE mass spectrometer coupled to the UHPLC was used for the final
determination, the mass spectrometer operating in negative electro-
spray ionization and MRM mode.
2.2.5. Total serum lipids
Total cholesterol and triglycerides were measured in serum on a
Cobas 8000 modular analyzer system (Roche/Hitachi, Switzerland) by
enzymatic colorimetric tests using dedicated Roche's kits. The total lipid
content was then determined using the following equation according to
Phillips et al. (1989):
= × +
+
Total lipid content(g/L) (total cholesterol) 2.27 (triglycerides)
62.3.
2.3. Statistical analysis
The statistical analyses were performed using Statistica 13 (TIBCO
software Inc, United Kingdom) and RStudio (version 3.4.1; R Project for
Statistical Computing). Statistical significance was set at p < 0.05.
Statistical analyses were performed on the 19 chemicals with detection
frequencies (DF) > 40%. We calculated the Spearman correlation
coefficients between the concentrations of the 19 chemicals included in
our analyses.
Two approaches were followed for the statistical exploration:
monopollutant and multipollutant models. Our objective was to com-
pare a classical monopollutant approach similar to those employed in
Dufour et al. (2018) and an innovative multipollutant approach based
on the use of the multiple imputation and the WQS methodology.
Thereby, firstly, an individual logistical model was computed for each
chemical, the outcome variable being the pathology status. On one
hand, if the DF for the chemical was above 70%, the xenobiotic con-
centrations (a natural logarithm transformation was applied to pollu-
tant concentrations in order to satisfy the criteria of normality and
measurements below the limit of quantification (LOQ) were replaced by
LOQ × DF (Dufour et al., 2018)) were incorporated in the model. On
the other hand, for pollutants with DF ranging between 40 and 70%, the
contamination status (detected vs. non-detected) was used for model
calculation.
Secondly, to explore the associations between mixtures of pollutants
and the thyroid pathology status, we used the multiple imputation in
conjunction with WQS regression. The multiple imputation method was
proposed by Lubin et al. (2004) to manage measurements below the
LOQ. This method used a maximum likelihood algorithm to randomly
select, from an appropriate distribution, values for the observations
below the LOQ. Lubin et al. (2004) demonstrated that the multiple
imputation method produces good parameter estimates unless the
proportion of measurements below the LOQ is very high, we chose thus
to limit our analyses on chemicals with DF > 40%. Using this ap-
proach, we generated 5 complete sets of data and each dataset was
analyzed using WQS regression. WQS models were computed according
to the methodology proposed by Gennings et al. (2010) and improved












where g(μ) is the link function between the outcome variable and the
predictor variables. β0 is the intercept, z’ is a vector of covariates and ϕ
the vector of regression coefficients associated to these covariates. The
term ∑ = w qi 1
c
i i represents the WQS index, c is the number of chemicals
included in the index, qi defines the score for the ith component ac-
cording to the quantile and wi is the weight attributed to the ith che-
mical. The set of weights is computed using an optimization approach
which maximizes the likelihood of the regression model. The weights
are constrained to be positive and sum to one and are empirically es-
timated through the use of bootstrap samples. Finally, β1 represents the
regression coefficient for the WQS index and is constrained to be non-
positive or non-negative. For this analysis, the link function g(μ) was
assumed to be a logit link because of the binary nature of the outcome
variable (pathology status), the chemicals included in the WQS index
were scored according to quartiles and qi = 0, 1, 2, or 3 if the con-
centration value was in 1st, 2nd, 3rd and 4th quartile, respectively and
500 bootstrap samples were generated from our full data set to estimate
the weights wi. WQS models were constructed with β1 constrained to be
non-negative and additional models were computed with β1 con-
strained to be non-positive to determine whether some pollutants were
associated with reduced risk for thyroid pathologies (Deyssenroth et al.,
2018). Finally, the parameters estimates computed with each imputed
dataset were combined according the formula of Rubin (Rubin, 2004;
Lubin et al., 2004). Two parameters are important for the interpretation
of the WQS regression model. First, we considered the significance as-
sociated with β1 to determinate whether there is an association between
the WQS index and the thyroid pathology status. Second, we analyzed
the index weights to identify “bad actors” which are the chemicals ef-
fectively associated with the outcome. For this analysis, pollutants as-
sociated with a weight above 0.075 were considered as bad actors
(Carrico et al., 2015; Christensen et al., 2013; Czarnota et al., 2015).
Monopollutant and multipollutant models were constructed for hy-
pothyroidism and hyperthyroidism status separately but also, assuming
that both pathologies are linked by a common immunopathological
pathway (McLachlan et al., 2007), for any thyroid autoimmune disease
status. All the models were adjusted for age, sex, smoking status, body
mass index (BMI) and delay (in months) between sampling and start of
the recruitment (to account for potential trend in measured POPs
during the collection period). Additional models were computed (only
for hypothyroidism and hyperthyroidism) in order to assess the ro-
bustness of our main observations: first, as PCB and organochlorine
pesticide concentrations are usually adjusted for serum lipids, we cre-
ated additional models including all the variables from the final models
plus the total serum lipid levels (natural log transformed). Secondly, we
reran final models by omitting the BMI in order to investigate the in-
fluence of this parameter. Thirdly, given the importance of the gender
on the thyroid function and the prevalence of autoimmune thyroid
diseases, we computed models by considering only female individuals.
And finally, for both pathologies, we split chemicals into two groups:
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those that were positively associated with the pathology (based on the
OR computed in monopollutant model) and those that were negatively
associated with the pathology. WQS index were computed for both
group and the positive and the negative index were then combined in
the same model, consequently, we computed one model with two WQS
index for hypothyroidism and one model with two index for hy-
perthyroidism. Data imputation, WQS regression models and combi-
nation of the parameter estimates were computed using the R package
miWQS (Hartgarten and Wheeler, 2018).
3. Results
Characteristics of the population were gathered in Table 1. As ex-
pected, the cases were mostly women (71.8%). The mean age and BMI
in the overall population were 44 years and 24.9 kg/m2, respectively,
and 21% of individuals were smoker. The DFs for the 54 POPs studied
in this work were gathered in Table 2. Among these chemicals, 19 had
DF above 40% and were thus included in the statistical analyses: 6
PFASs, 9 POHs, 1 organochlorine pesticide and 3 PCBs. The descriptive
statistics for these chemicals are presented in Table 3. None of the BFRs
was highlighted in more than 40% of the individuals and only PBDE 47
(31.8%) and PBDE 153 (38.5%) were measured in more than 20% of
the population. Among PFASs, PFOS, PFOA, PFHxS and PFNA were
highlighted in almost all the individuals with median concentrations of
3612, 1600, 805 and 510 pg/mL, respectively. Only the PFHpA was
non-detected in most of the individuals. The DFs were also high for the
chlorinated POHs namely the PCP and the OH-PCBs. PCP, 4-OH-CB
187, 4-OH-CB 107 and 4-OH-CB 146 were measured in the nearly entire
population with median concentrations of 554, 34.5, 32.0 and 29.2 pg/
mL, respectively. The DFs for brominated POHs were largely lower
except for 2,4,6-TBP (56.3%) and to a lower extent TBBPA (38.7%).
Among organochlorine pesticides, 4,4′-DDE was determined in 50.4%
of the individuals with a median concentration of 404.2 pg/mL and
among the other pesticides, only β-HCH (39.1%) and HCB (37.4%) had
DFs above 10%. PCB 138 was measured in 45.4% of the individuals
while PCB 153 and PCB 180 were detected in 92.0% and 89.5% of the
population, respectively with respective median concentrations of 325
and 265 pg/mL. DFs and median concentrations according to the dis-
ease status were gathered in supplemental materials Table S1. Except
2,4,6-TBP, chemicals were mostly significantly correlated with each
other: 153 Spearman correlation coefficients out the 171 were sig-
nificant. Significant coefficients ranged from 0.13 to 0.94 (supple-
mental materials Fig. S1).
The results of monopollutant analyses are gathered in Table 4.
PFUdA, PFOA, PFNA, PFOS, PFDA and 3-OH-CB 138 were significantly
associated with reduced odds of thyroid autoimmune diseases status
while 4-OH-CB 146, 4,4′-DDE and PCB 138 were linked to increased
odds of thyroid pathologies status. The profiles of the pollutants asso-
ciated with hyperthyroidism or with hypothyroidism were different:
higher contamination by PFHxS, PFOA, PFNA, PFOS, PFDA, 3-OH-CB
138 and 2,4,6-TBP were associated with reduced odds of hyperthyr-
oidism while only PFOA, PFNA and PFDA were in relation with a
reduction of the odds for hypothyroidism. On the other hand, 4-OH-CB
146, 4-OH-CB 172, PCB 180 and PCB 138 were linked to increased odds
for this pathology, a borderline significant association was also high-
lighted with 4,4′-DDE.
The results of the WQS regression models are presented in Table 5.
A quartile increase of the WQS index was associated with higher odds of
having an autoimmune thyroid pathology (OR = 4.83; 95% CI:
1.38–16.9) and hypothyroidism (OR = 98.1; 95% CI: 5.51–1747) but
not with higher odds of suffering from hyperthyroidism (OR = 0.57;
95% CI: 0.11–2.99). WQS regressions were also performed to determine
whether there were negative associations between the pollutant mix-
ture and the different pathologies. WQS indexes were found to be sig-
nificantly linked to reduced odds of autoimmune thyroid pathology
(OR = 0.17; 95% CI: 0.06–0.46), hyperthyroidism (OR = 0.002; 95%
CI: 0.00–0.09) and hypothyroidism (OR = 0.22; 95% CI: 0.06–0.77).
Table 6 shows estimated pollutant weights for each significant WQS
index. The most heavily weighted chemical for the positive association
between mixture and any autoimmune thyroid diseases was 3-OH-CB
180 (w = 0.249) followed by PCB 138 (w = 0.190), 4,4′-DDE
(w = 0.180) and 4-OH-CB 146 (w = 0.096). The weight index profile
was similar for hypothyroidism and was dominated by PCB 138
(w = 0.210), 3-OH-CB 180 (w = 0.197), 4-OH-CB 146 (w = 0.188)
and 4,4′-DDE (w = 0.156). On the other hand, reduced odds of having
an autoimmune thyroid pathology was associated with 3-OH-CB 138
(w = 0.187), PFOA, (w = 0.135), PFDA (w = 0.128), PFUdA
(w = 0.110), PFOS (w = 0.109), PFNA (w = 0.108), PCP (w = 0.080)
and 2,4,6-TBP (w = 0.076). 3-OH-CB 138 was also heavily linked with
reduced odds of hyperthyroidism (w = 0.395), the other chemicals
with elevated weight were 2,4,6-TBP (w = 0.141), PFDA (w = 0.116)
and PCP (w = 0.095). Finally, PFNA (w = 0.282), PFDA (w = 0.280)
and PFOA (w = 0.149) had the highest weights in the WQS index as-
sociating chemical mixture and reduced odds of hypothyroidism.
Across sensitivity analyses, associations between WQS indexes and
the thyroid disease prevalence remained stable and chemicals high-
lighted following the weights were identical when the models were
additionally adjusted for total serum lipids (supplemental materials
Tables S2 and S3). The observations were the same when BMI was
omitted from the models, except that some additional chemicals re-
ceived more important weight and were highlighted as linked to the
pathology (e.g. PCB 180 for increased risk of hypothyroidism and
PFHxS for decreased risk of hyperthyroidism) (supplemental materials
Tables S2 and S4). Consequently our results seemed to be not sig-
nificantly influenced by the total serum lipids or the BMI. Conversely,
models restricted to female individuals provided slightly different re-
sults. Association between WQS index and increased risk for hy-
pothyroidism remained significant while the link with reduced risk for
hypothyroidism became insignificant (OR = 0.24; 95% CI: 0.04–1.43)
and those with reduced risk for hyperthyroidism became borderline
(OR = 0.03; 95% CI: 0.00–1.43). Chemicals selected according to
weight were also slightly different with 4-OH-CB 107 additionally
identified as linked with increased risk for hypothyroidism and PFOS
and PFUdA linked to reduced risk for hyperthyroidism instead of PCP
Table 1
Characteristic of cases and controls.
Cases Controls
No Mean Range % No Mean Range %
Age, years 78 43.8 [17–74] 44.1 [19–71]
BMI, kg/m2 77 25.1 [17.5–45.8] 24.9 [16.3–37.6]
Sex
Male 22 28.2% 44 27.5%
Female 56 71.8% 116 72.5%
Smoking status
Smoker 18 23.1% 32 20.0%
Non-smoker 60 76.9% 128 80.0%
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and PFDA (supplemental materials Tables S2 and S5). Nevertheless,
these changes may be the consequence of the reduction of the statistical
power, models restricted to men would have been informative but,
unfortunately, the number of male individuals was too low to perform
statistical analyses. Regarding the models with positive and negative
index combined (supplemental materials Table S6), chemicals asso-
ciated with hypothyroidism were the same than those identified by
regular models (PCB 138, 3-OH-CB 180, 4-OH-CB 146 and 4,4′-DDE
positively associated with the pathology and PFNA, PFDA and PFOA
negatively associated). On the other hand, unlike our initial model,
model considering chemicals split in two groups highlighted a sig-
nificant positive association with hyperthyroidism (OR = 84.1; 95% CI:
3.68–13588). The compounds highlighted as bad actors were 3-OH-CB
180, 4,4′-DDE and PCB 138. This methodology, called “grouped WQS”,
was proposed by Wheeler and Czarnota (2016) and seems to be in-
formative when two groups of chemicals (one positively associated with
the pathology and one negatively associated with the pathology) are
present. Nevertheless, currently, this methodology is not fully described
in the literature, consequently, it is actually difficult to discuss more
extensively these results.
4. Discussion
We focused our investigations on autoimmune thyroid disorders.
The first reason was that autoimmunity is the most common etiology
for hypothyroidism and hyperthyroidism and is thus a major health
concern. Secondly, several epidemiological studies showed positive
associations between POP exposure and the presence of autoimmune
thyroid antibodies (Turyk et al., 2008; Gaum et al., 2016). Another link
between pollutants and thyroid autoimmunity was proposed by
Webster et al. (2014). Based on their results, they established the
“multiple hit hypothesis”. This hypothesis suggests that individuals
with multiple stressors to their thyroid function (e.g. autoimmune
thyroid antibodies) may be more susceptible to thyroid disruption by
pollutants.
Hashimoto's and Graves' diseases are two disorders linked to an
autoimmune mechanism. Due to the potential immunotoxicity high-
lighted for some POPs (Langer et al., 2005), we hypothesized that an
increased risk for both pathologies could be associated to a similar
mixture of immunotoxic pollutants. We computed models for both
disorders together. Nevertheless, our results showed that hypothyr-
oidism and hyperthyroidism were associated with very different pro-
files of pollutants which suggests that the pathological pathways linking
pollutants with both disorders were probably different in our popula-
tion, and demonstrates that our models including both diseases were
not relevant.
WQS regressions were used to assess the associations between au-
toimmune thyroid pathologies and mixtures of environmental POPs.
These statistical models highlighted that an increase of the mixture
index was associated with a higher odds of Hashimoto's hypothyr-
oidism. In this index, PCB 138, 3-OH-CB 180, 4-OH-CB 146 and 4,4′-
DDE had the heaviest weights. Computed OR was surprisingly high
(98.1), this could suggest that considering mixture effects reveals more
significant association between exposure and pathologies. For instance,
Lee et al. (2006) also highlighted very high ORs (up to 38.3) when
assessing the association between a mixture of 6 POPs and the incidence
of diabetes. Nevertheless, we cannot exclude that our results were af-
fected by an unexpected bias or by inverse causality. Moreover, in the
ideal use of WQS regression, study data are split into training dataset
used to estimate the weights attributed to chemicals and validation
dataset used to test the statistical significance. Given the relative low
number of participants in our study, we chose not to split our dataset,
consequently, our models were not validated and p values should not be
used for strict inferences but rather as a guide for representing strength
of associations (Gennings et al., 2010). Nevertheless, we computed
WQS models with training and validating datasets as sensitivity ana-
lyses (supplementary materials, Table S7). As expected, the statistical
power of our analyses was reduced and none of the associations re-
mained significant. However, it is interesting to observe that the odds
ratio were much less extreme (for instance, OR = 12 versus OR = 98
for increased risk of hypothyroidism) which suggest that the non-op-
timal use of the WQS regression may result in overfitting of the coef-
ficient estimates. Moreover, small sample size resulted in very im-
precise estimates and large confidence intervals. Consequently, our
results should be considered with caution and confirmed by larger scale
studies.
Table 2
Limits of quantification (LOQs) and detection frequencies (DFs) for all the
chemicals assessed.














PBB 153 4.2 0.0
PBDE 47 3.7 31.8
PBDE 99 5.3 2.6
PBDE 100 2.5 3.1
PBDE 153 4.2 38.5
PBDE 154 6.0 6.2
PBDE 183 3.8 15.4




5-OH-BDE 47 2.3 1.3
6-OH-BDE 47 2.5 2.9





4-OH-CB 107 3.2 97.1
3-OH-CB 138 3.1 86.1
4-OH-CB 146 2.2 98.7
3-OH-CB 153 3.0 67.6
4-OH-CB 172 2.0 86.1
3-OH-CB 180 2.1 60.1



















PCB 138 150.0 45.4
PCB 153 70.0 92.0
PCB 180 50.0 89.5
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The observation that one PCB and two metabolites of PCBs were
positively associated with hypothyroidism was consistent with nu-
merous studies published in the literature. In laboratory, many authors
showed that PCBs reduced thyroxine (T4) levels in exposed rats (Bansal
and Zoeller, 2008; Crofton et al., 2005; Martin and Klaassen, 2010). The
implication of OH-PCBs has been less studied, however, it may be
preponderant. Indeed, these metabolites show higher structural simi-
larities with THs because of the presence of the phenol function. Con-
sequently, for instance, their binding capacities on transthyretin (a
blood transport protein for THs) are several orders of magnitude higher
than those of the native PCBs (Marchesini et al., 2008). Furthermore,
Meerts et al. (2004) showed that OH-PCBs were also able to reduce T4
levels in rat. Several epidemiological studies also highlighted that high
concentrations of PCBs were associated with reduced levels of thyroid
hormones and/or increased levels of TSH in human populations
(Abdelouahab et al., 2008; Benson et al., 2018; Gaum et al., 2016;
Persky et al., 2001; Turyk et al., 2007) which is consistent with the
clinical features of hypothyroidism. However, inverse associations have
also been reported (Bloom et al., 2009; Eguchi et al., 2015). Moreover,
studies exploring the association between PCB contamination and
thyroid disorders failed to highlight significant link (Donato et al.,
2008; Raffetti et al., 2018) but these studies did not focus on auto-
immune thyroid disorders. Furthermore, in these studies, OH-PCBs
were not measured while they could be important actors in the thyroid
Table 3
Means, medians, ranges, percentiles 25, 75 and 95 (pg/mL) for the chemicals with detection frequency > 40%.
Mean Median Min Max P25 P75 P95
PFHxS 1013.0 805.0 < LOQ 7450.0 530.0 1340.0 2182.0
PFOA 1873.2 1600.0 305.3 7094.0 1082.2 2310.0 4340.0
PFNA 625.3 510.0 111.0 2580.0 360.0 800.0 1402.2
PFOS 4384.0 3612.0 645.0 20565.0 2116.8 5450.0 11230.0
PFDA 329.6 270.0 < LOQ 1320.0 171.0 390.0 830.0
PFUdA 186.8 138.0 < LOQ 1019.0 < LOQ 230.0 530.0
PCP 1324.2 554.2 < LOQ 35940.0 < LOQ 1041.7 3582.0
2,4,6-TBP 74.6 53.3 < LOQ 1276.6 < LOQ 77.2 210.7
4-OH-CB 107 52.2 32.0 < LOQ 361.8 18.8 63.3 173.0
3-OH-CB 138 15.2 10.8 < LOQ 261.4 4.9 18.7 41.3
4-OH-CB 146 40.2 29.2 < LOQ 228.9 17.0 50.2 111.0
3-OH-CB 153 13.9 9.1 < LOQ 208.2 < LOQ 19.0 45.1
4-OH-CB 172 10.4 7.2 < LOQ 50.6 3.3 14.1 28.3
3-OH-CB 180 4.5 3.0 < LOQ 31.9 < LOQ 5.6 14.8
4-OH-CB 187 40.6 34.5 6.5 182.4 22.2 51.7 85.6
4,4′-DDE 931.2 404.2 < LOQ 24700.2 < LOQ 837.5 3020.6
PCB 138 182.3 < LOQ <LOQ 1009.8 < LOQ 243.9 454.3
PCB 153 405.7 325.8 < LOQ 2247.3 148.0 561.6 1023.7
PCB 180 329.6 265.3 < LOQ 1564.2 108.7 486.8 891.8
Table 4
Results from the monochemical models assessing potential associations with hypothyroidism, hyperthyroidism or any autoimmune thyroid diseases. Significant ORs
are in bold. All the models were adjusted for age, sex, smoking status, body mass index and delay (in months) between sampling and start of the recruitment.
Hypothyroidism Hyperthyroidism Any thyroid diseases
OR 95% CI OR 95% CI OR 95% CI
Continuous
Ln (PFHxS) 0.78 (0.21–2.86) 0.14 (0.03–0.63) 0.47 (0.19–1.15)
Ln (PFOA) 0.18 (0.04–0.82) 0.19 (0.05–0.74) 0.23 (0.08–0.62)
Ln (PFNA) 0.19 (0.05–0.79) 0.10 (0.02–0.45) 0.17 (0.06–0.46)
Ln (PFOS) 0.43 (0.12–1.50) 0.19 (0.06–0.64) 0.32 (0.14–0.75)
Ln (PFDA) 0.19 (0.05–0.81) 0.17 (0.05–0.57) 0.24 (0.10–0.57)
Ln (PCP) 0.91 (0.55–1.53) 0.84 (0.41–1.73) 0.80 (0.53–1.22)
Ln (4-OH-CB 107) 1.43 (0.58–3.49) 0.86 (0.35–2.11) 0.94 (0.50–1.76)
Ln (3-OH-CB 138) 1.17 (0.40–3.45) 0.10 (0.02–0.47) 0.40 (0.18–0.90)
Ln (4-OH-CB 146) 13.7 (2.03–92.7) 1.14 (0.37–3.56) 2.61 (1.13–6.04)
Ln (4-OH-CB 172) 4.95 (1.48–16.6) 1.00 (0.56–1.78) 1.84 (0.92–3.66)
Ln (4-OH-CB 187) 3.76 (0.55–25.5) 0.32 (0.04–2.40) 0.91 (0.25–3.32)
Ln (PCB 153) 1.34 (0.34–5.24) 0.33 (0.08–1.47) 0.63 (0.24–1.70)
Ln (PCB 180) 3.64 (1.18–11.2) 0.93 (0.27–3.24) 1.83 (0.83–4.01)
Binary
PFUdA (detected vs non-detected) 0.30 (0.06–1.50) 0.25 (0.04–1.52) 0.30 (0.09–0.96)
2,4,6-TBP (detected vs non-detected) 0.65 (0.16–2.72) 0.20 (0.04–0.91) 0.43 (0.16–1.18)
3-OH-CB 153 (detected vs non-detected) 1.51 (0.23–9.74) 0.59 (0.10–3.39) 1.06 (0.31–3.62)
3-OH-CB 180 (detected vs non-detected) 2.43 (0.48–12.3) 3.37 (0.54–21.0) 2.19 (0.63–7.60)
4,4′-DDE (detected vs non-detected) 4.47 (0.96–20.8) 1.83 (0.33–10.2) 3.08 (1.02–9.35)
PCB 138 (detected vs non-detected) 8.88 (1.30–60.6) 3.06 (0.60–15.5) 4.63 (1.37–15.6)
Table 5
Results from the multipollutant models assessing potential associations between
the thyroid pathologies and the WQS index. Significant ORs are in bold. All the
models were adjusted for age, sex, smoking status, body mass index and delay
(in months) between sampling and start of the recruitment.
OR 95% CI p-value
WQS increased risk for hypothyroidism 98.1 (5.51–1747) 0.002
WQS reduced risk for hypothyroidism 0.22 (0.06–0.77) 0.019
WQS increased risk for hyperthyroidism 0.57 (0.11–2.99) 0.501
WQS reduced risk for hyperthyroidism 0.002 (0.00–0.09) 0.002
WQS increased risk for any thyroid disease 4.83 (1.38–16.9) 0.015
WQS reduced risk for any thyroid disease 0.17 (0.06–0.46) <0.001
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disruption by PCBs.
The presence of 4,4′-DDE among pollutants heavily weighted in the
index related to hypothyroid is relatively consistent with the literature.
Liu et al. (2015) observed a decrease of the thyroid hormone levels in
rats exposed to a mixture of PCB 153 and 4,4′-DDE. Additionnally, our
results are support the findings of Lopez-Espinosa et al. (2009). These
authors reported a negative association between the 4,4′-DDE con-
centrations and the T4 levels and a positive association between 4,4′-
DDE contamination and TSH levels in a cohort of pregnant women from
Spain. Nevertheless, contradictory results have also been reported in
some other epidemiological studies (Blanco-Muñoz et al., 2016; Meeker
et al., 2007).
The association between a mixture of chemicals and reduced odds
for hypothyroidism status was also studied. A significant correlation
was highlighted with 3 PFASs, namely PFOA, PFNA and PFDA. This
observation was not consistent with the literature because some in-
vestigations performed in laboratories showed that animals exposed to
PFASs had reduced levels of thyroid hormones (Luebker et al., 2005;
Martin et al., 2007). Moreover, several epidemiological studies have
linked high levels of PFASs with higher incidence of thyroid disorders
(Lopez-Espinosa et al., 2012; Melzer et al., 2010), but the PFAS con-
tamination was 5–10 folds higher in these populations than in the
present study.
Regarding WQS indexes computed for hyperthyroidism, 3 OH-CB
138, 2,4,6-TBP, PFDA and PCP were in relation with lower odds for
hyperthyroidism while no index was associated with increased odds.
The present observation of a lower risk of hyperthyroidism asso-
ciated with the pollutant mixture was consistent with several laboratory
animal studies reporting lower TH levels in exposed animals than in
controls (Bansal and Zoeller, 2008; Crofton et al., 2005; Liu et al., 2015;
Luebker et al., 2005; Martin et al., 2007; Martin and Klaassen, 2010),
but were inconsistent with the results of the epidemiological work
carried out by Langer et al. (2007). Indeed, they highlighted an ele-
vated number of individuals presenting subclinical hyperthyroidism
among people highly exposed to PCBs in a Slovakian population. Given
the case-control design of our investigation, we can suspect a reverse
causality; hyperthyroid disease is associated with an accelerated me-
tabolism, consequently the metabolization and the elimination of some
POPs could be boosted in our hyperthyroid individuals which would
have led to reduced levels of chemicals.
In this study, we performed the comparison of two approaches; a
monopollutant approach where an individual statistical model was
computed for each chemical, and a multipollutant approach where
WQS regression was employed to consider all the compounds within a
single model. When assessing the link between pollutants and reduced
odds of hypothyroid, both approaches highlighted exactly the same
compounds, but some divergences occurred when evaluating the asso-
ciations with increased odds for hypothyroidism. On one hand, the
multipollutant approach allowed to select two pollutant (3-OH-CB 180
and 4,4′-DDE) which would not have been identified using the in-
dividual statistical model, highlighting the importance of considering
mixture effect. On the other hand, 4-OH-CB 172 and PCB 180 were not
selected by the multipollutant approach, which suggests that the effect
observed in the individual model might be due to the important cor-
relations with 4-OH-CB 146 (r = 0.82 and r = 0.74, respectively).
Similar conclusions could be drawn for hyperthyroidsism, the multi-
pollutant approach allowed the identification of an additional major
actor (PCP) while some PFASs were dismissed meaning that the pair-
wise correlations between PFDA and all the other PFASs (r ranging
between 0.43 and 0.87) resulted in the artifactual highlighting of sev-
eral PFASs in the monochemical statistics. In comparison with the
monopollutant analysis, WQS regression seemed to be more sensitive in
identifying chemicals that were not selected in monopollutant approach
and more convenient in order to reveal the true bad actors among
groups of highly intercorrelated chemicals (Carrico et al., 2015;
Czarnota et al., 2015). The method for selecting a reasonable threshold
to identify bad actors is still under research (Czarnota et al., 2015), the
inverse of the number of chemicals (in this study: 1/19 = 0.053) may
be an appropriate choice, nevertheless we chose a higher threshold
(0.075) in order to promote specificity, obviously, the sensitivity was
consequently reduced and some additional pollutants could have been
selected with a more permissive threshold.
However, the WQS methodology is not without limitations. WQS
model is only able to explore the mixture effect in one direction. Thus,
the chemicals with opposite effects cannot be assessed in the same
model. Moreover, using WQS regression implied that the effect is linear
and that there is no interaction among the compounds incorporated
into the index, WQS is thus not suitable to study non-monotonic ex-
posure-outcome curves or synergistic or antagonist effects (Carrico
et al., 2015). Notwithstanding these limitations, WQS regression re-
presents an important step forward the understanding on how mixtures
of POPs can interfere with the thyroid system in human. Another
Table 6
Weights from weighted quantile sum regression for pollutant index and risk of hypothyroidism, hyperthyroidism and any autoimmune thyroid disease. OR for
increased risk of hyperthyroidism was not significant, weights were thus not computed for this model. Weights above 0.075 are in bold.




Increased risk for any thyroid
disease
Reduced risk for any thyroid disease
Chemical Weight Chemical Weight Chemical Weight Chemical Weight Chemical Weight
PCB 138 0.210 PFNA 0.282 3-OH-CB 138 0.395 3-OH-CB 180 0.249 3-OH-CB 138 0.187
3-OH-CB 180 0.197 PFDA 0.280 2,4,6-TBP 0.141 PCB 138 0.190 PFOA 0.135
4-OH-CB 146 0.188 PFOA 0.149 PFDA 0.116 4,4′-DDE 0.180 PFDA 0.128
4,4′-DDE 0.156 PCP 0.057 PCP 0.095 4-OH-CB 146 0.096 PFUdA 0.110
4-OH-CB 172 0.062 PFUdA 0.054 PFHxS 0.070 4-OH-CB 107 0.066 PFOS 0.109
PCB 180 0.059 PCB 153 0.040 PFUdA 0.048 4-OH-CB 172 0.051 PFNA 0.108
4-OH-CB 107 0.043 PFOS 0.038 PFOS 0.043 PCB 180 0.026 PCP 0.080
3-OH-CB 153 0.024 2,4,6-TBP 0.037 PFOA 0.027 3-OH-CB 153 0.020 2,4,6-TBP 0.076
2,4,6-TBP 0.022 PFHxS 0.024 4,4′-DDE 0.024 2,4,6-TBP 0.015 PCB 153 0.036
3-OH-CB 138 0.019 3-OH-CB 180 0.006 PFNA 0.016 4-OH-CB 187 0.014 PFHxS 0.025
PCP 0.007 3-OH-CB 153 0.004 3-OH-CB 153 0.004 PCP 0.012 4-OH-CB 172 0.003
4-OH-CB 187 0.003 4-OH-CB 187 0.004 4-OH-CB 172 0.004 PFHxS 0.012 4-OH-CB 187 0.002
PFUdA 0.002 PCB 138 0.004 PCB 153 0.003 PCB 153 0.012 PCB 138 <0.001
PCB 153 0.002 3-OH-CB 138 0.003 4-OH-CB 187 0.003 3-OH-CB 138 0.011 3-OH-CB 153 <0.001
PFHxS 0.002 PCB 180 0.003 PCB 180 0.003 PFOS 0.010 PCB 180 <0.001
PFOS 0.002 4-OH-CB 107 0.003 4-OH-CB 146 0.002 PFUdA 0.009 4-OH-CB 146 <0.001
PFOA <0.001 4,4′-DDE 0.003 PCB 138 0.002 PFOA 0.009 3-OH-CB 180 <0.001
PFDA <0.001 4-OH-CB 172 0.003 4-OH-CB 107 0.002 PFNA 0.009 4,4′-DDE <0.001
PFNA <0.001 4-OH-CB 146 0.003 3-OH-CB 180 0.001 PFDA 0.008 4-OH-CB 107 <0.001
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strength of this study was the assessment of 54 chemicals in a human
population. Among them, 19 were highlighted in more than 40% of the
individuals and could thus be incorporated in the statistical analyses.
Unfortunately none of the BFRs measured had a sufficient DF to be
included into the statistical models, but that means that BFR con-
tamination in Belgium was limited and thus the influence of these
chemicals on thyroid function could be less significant regarding the
other chemicals assessed. Conversely, 9 POHs among the 16 assessed
were highlighted in most of the participants and were thus included in
the statistical analyses. The associations between POHs and human
thyroid function were rarely assessed in epidemiological studies.
However, POHs were measured in several populations worldwide
(Dufour et al., 2017) and, as mentioned above for OH-PCBs, they are
suspected to be potent thyroid disruptors, in particular by presenting a
high affinity for the transthyretin (Cheek et al., 1999; Hamers et al.,
2006; Marchesini et al., 2008). Investigations exploring the link be-
tween POH exposure and thyroid disruption should thus be encouraged.
However, our work suffered from several limitations. Given the
case-control design of our investigation, we may be subject to a reverse
causality since lower concentrations observed for several chemicals in
hyperthyroid patient could be the consequence of an accelerated me-
tabolism. Moreover, the positive correlation observed between some
POPs and hypothyroidism could be the result of the slowed metabolism
characteristic of a reduced thyroid function. To definitely establish the
etiology direction, prospective studies assessing associations between
mixtures of pollutants and thyroid disorder incidence should be per-
formed in the future. Moreover, because most of the case participants
were under treatment at the enrollment in our study, their TH levels
were thus stabilized and consequently, we could not assess the corre-
lations between the POP contamination and the levels of THs.
Longitudinal investigations should allowed to explore relation between
exposure to a mixture of POPs and TH levels.
Another limitation of our work is the relative low number of in-
dividuals which decreased the statistical power of the analyses and
prevented the use of advanced analyses, for instance, by stratifying
models by sex (we performed analyses for women, but the number of
male individuals was too low to compute analyses restricted to men) or
by age groups or by splitting our data into training and validation da-
tasets. Given this limitation, we should consider the present study as a
preliminary, hypothesis-generating investigation. Moreover, the re-
cruitment of the population from which the controls originated was not
originally designed for the purpose of this study but in order to be re-
presentative of the general population. Thyroid pathology status is thus
unknown for a large proportion of these individuals especially since we
did not assess the presence of thyroid peroxidase antibodies or TSH-
receptor antibodies in our control cohort. Thus, we could not be certain
that our control cohort did not include individuals with thyroid dis-
order. Nevertheless, given the prevalence of overt hypo- and hy-
perthyroidism in Europe (1–2% for combined pathologies, Garmendia
Madariaga et al., 2014), the potential bias seemed to us acceptable.
Moreover, according to the “multiple hit hypothesis” of Webster et al.
(2014), it would have been interesting to make a comparison between
mixture of pollutants measured in the thyroid patients and in in-
dividuals with thyroid antibodies but not diagnosed for thyroid dis-
orders. Other potential important confounding factors as blood sele-
nium, iodine status or blood lipids were not controlled. These variables
should be included on future larger scale studies in order to improve
result confidence. Finally, our analyses involved 5 POP families which
are considered as potential thyroid disruptors (Boas et al., 2012), but
some other chemicals such as phthalates, bisphenol A, and UV-filters
are also suspected to be thyroid disruptors (Boas et al., 2012) and could
have been included in our investigations. However, these chemicals are
non-persistent pollutants and their concentrations measured in one
urine sample may be not representative of the long-term exposure. To
accurately assess the exposure to these pollutants in human population
for epidemiological studies is certainly a major challenge for the future.
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